![](/img/cover-not-exists.png)
ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy
Veenstra, V. L., Damhofer, H., Waasdorp, C., van Rijssen, L. B., van de Vijver, M. J., Dijk, F., Wilmink, H. W., Besselink, M. G., Busch, O. R., Chang, D. K., Bailey, P. J., Biankin, A. V., Kocher, H.Volume:
7
Language:
english
Journal:
Oncogenesis
DOI:
10.1038/s41389-018-0096-9
Date:
November, 2018
File:
PDF, 970 KB
english, 2018